Literature DB >> 31115740

Do young women with unexplained infertility show manifestations of decreased ovarian reserve?

Noa Abrahami1,2, Ido Izhaki3, Johnny S Younis4,5.   

Abstract

PURPOSE: To investigate whether unexplained infertility at a young age demonstrates manifestations of decreased ovarian reserve.
METHODS: A total of 100 women were divided into two equally sized groups. The study group comprised women aged ≤ 37 years diagnosed with unexplained infertility, and the control group included age-matched women with either mechanical factor or severe male factor infertility.
RESULTS: Both groups were comparable in their basic characteristics. Overall, women with unexplained infertility presented with inferior ovarian reserve results set against women of the control group. The number of ≥ 14-mm follicles on the day of hCG administration was significantly lower in the study compared with the control group (7.0 ± 4.5 vs. 10.4 ± 4.1 follicles, respectively, P < 0.001). Likewise, basal serum FSH was higher in the study compared with the control group (8.4 ± 5.5 vs. 6.4 ± 1.7 IU/L, respectively, P = 0.015), while antral follicle count was lower (10.9 ± 6.6 vs. 16.2 ± 6.6 follicles, respectively, P < 0.001). Furthermore, women with unexplained infertility required a higher total dose of FSH for ovarian stimulation (2,923 ± 1,701 vs. 2,196 ± 941 IU/L, respectively, P = 0.010), but exhibited a lower number of retrieved oocytes (9.3 ± 6.3 vs. 15.6 ± 7.9 oocytes, respectively, P < 0.001), alongside a lower number of achieved embryos (5.3 ± 4.0 vs. 8.0 ± 4.7 embryos, respectively, P = 0.002). Interestingly, the cumulative clinical pregnancy rate was not significantly different between the two groups (44% vs. 58%, respectively, P = 0.163).
CONCLUSIONS: Young women ≤ 37 years of age with unexplained infertility have clear manifestations of sub-optimal ovarian reserve set against controls. Our findings suggest that unexplained infertility at a young age may be a risk factor for developing poor ovarian response, specifically as a quantitative, rather than a qualitative, risk factor.

Entities:  

Keywords:  (Basal) Ovarian reserve tests; Bologna criteria; Ovarian hyperstimulation; Ovarian reserve; Unexplained infertility

Mesh:

Year:  2019        PMID: 31115740      PMCID: PMC6603106          DOI: 10.1007/s10815-019-01467-0

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  56 in total

1.  Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype.

Authors:  M Perez Mayorga; J Gromoll; H M Behre; C Gassner; E Nieschlag; M Simoni
Journal:  J Clin Endocrinol Metab       Date:  2000-09       Impact factor: 5.958

Review 2.  A systematic review of tests predicting ovarian reserve and IVF outcome.

Authors:  F J Broekmans; J Kwee; D J Hendriks; B W Mol; C B Lambalk
Journal:  Hum Reprod Update       Date:  2006-08-04       Impact factor: 15.610

3.  Antimüllerian hormone levels and antral follicle counts are not reduced compared with community controls in patients with rigorously defined unexplained infertility.

Authors:  Eleni A Greenwood; Marcelle I Cedars; Nanette Santoro; Esther Eisenberg; Chia-Ning Kao; Daniel J Haisenleder; Michael P Diamond; Heather G Huddleston
Journal:  Fertil Steril       Date:  2017-12       Impact factor: 7.329

4.  Elevated day 3 FSH/LH ratio: a marker to predict IVF outcome in young and older women.

Authors:  Berna Seckin; Figen Turkcapar; Gulnur Ozaksit
Journal:  J Assist Reprod Genet       Date:  2011-12-20       Impact factor: 3.412

5.  Is there a link between an extremely poor response to ovarian hyperstimulation and early ovarian failure?

Authors:  D Nikolaou; S Lavery; C Turner; R Margara; G Trew
Journal:  Hum Reprod       Date:  2002-04       Impact factor: 6.918

Review 6.  World Health Organization reference values for human semen characteristics.

Authors:  Trevor G Cooper; Elizabeth Noonan; Sigrid von Eckardstein; Jacques Auger; H W Gordon Baker; Hermann M Behre; Trine B Haugen; Thinus Kruger; Christina Wang; Michael T Mbizvo; Kirsten M Vogelsong
Journal:  Hum Reprod Update       Date:  2009-11-24       Impact factor: 15.610

Review 7.  Age-related infertility and unexplained infertility: an intricate clinical dilemma.

Authors:  Edgardo Somigliana; Alessio Paffoni; Andrea Busnelli; Francesca Filippi; Luca Pagliardini; Paola Vigano; Paolo Vercellini
Journal:  Hum Reprod       Date:  2016-04-08       Impact factor: 6.918

8.  Elevated day 3 follicle-stimulating hormone/luteinizing hormone ratio >or= 2 is associated with higher rates of cancellation in in vitro fertilization-embryo transfer cycles.

Authors:  Kimberly E Liu; Ellen M Greenblatt
Journal:  Fertil Steril       Date:  2007-11-26       Impact factor: 7.329

9.  First polar body and nucleolar precursor body morphology is related to the ovarian reserve of infertile women.

Authors:  Johnny S Younis; Orit Radin; Nitsa Mirsky; Ido Izhaki; Tatyana Majara; Shalom Bar-ami; Moshe Ben-ami
Journal:  Reprod Biomed Online       Date:  2008-06       Impact factor: 3.828

10.  Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach.

Authors:  Simone L Broer; Jeroen van Disseldorp; Kimiko A Broeze; Madeleine Dolleman; Brent C Opmeer; Patrick Bossuyt; Marinus J C Eijkemans; Ben-Willem J Mol; Frank J M Broekmans
Journal:  Hum Reprod Update       Date:  2012-11-27       Impact factor: 15.610

View more
  2 in total

1.  Special characteristics, reproductive, and clinical profile of women with unexplained infertility versus other causes of infertility: a comparative study.

Authors:  Charalampos Siristatidis; Abraham Pouliakis; Theodoros N Sergentanis
Journal:  J Assist Reprod Genet       Date:  2020-06-05       Impact factor: 3.412

2.  Effects of Bushen Huoxue method for female with decreased ovarian reserve: A protocol for systematic review and meta-analysis.

Authors:  Zhuoting Xie; Yin Li; Zehua Chen; Qiuyu Cao; Chunren Zhang; Yang Fei; Kunyin Li; Yongge Guan
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.